Top Track 250

The late Sir Allen McClay established this pharmaceuticals developer in 1968. Now in its 50th year, it has grown to provide research, development and commercialisation services to more than 600 international biopharma companies. Led by chairman and chief executive Alan Armstrong, 59, it is investing £50m this year to upgrade the cold-storage facilities at its global headquarters in Northern Ireland and its European campus in Ireland.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyAlmac Group
ActivityPharmaceuticals manufacturer
LocationCo Armagh
Sales £m531.4
Operating profit £m34.2
Main shareholdersMcClay Foundation (100%)

If applicable:

* supplied by company   † annualised figure   ‡  profit = ebitda